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A dinuclear ruthenium(II) phototherapeutic that
targets duplex and quadruplex DNA†
Stuart A. Archer,a Ahtasham Raza,b Fabian Dro¨ge,a Craig Robertson,a
Alexander J. Auty,a Dimitri Chekulaev,a Julia A. Weinstein, a Theo Keane, a
Anthony J. H. M. Meijer, a John W. Haycock,*b Sheila MacNeil*b
and James A. Thomas *a
With the aim of developing a sensitizer for photodynamic therapy, a previously reported luminescent
dinuclear complex that functions as a DNA probe in live cells was modiﬁed to produce a new iso-
structural derivative containing RuII(TAP)2 fragments (TAP ¼ 1,4,5,8-tetraazaphenanthrene). The structure
of the new complex has been conﬁrmed by a variety of techniques including single crystal X-ray analysis.
Unlike its parent, the new complex displays Ru / L-based 3MLCT emission in both MeCN and water.
Results from electrochemical studies and emission quenching experiments involving guanosine
monophosphate are consistent with an excited state located on a TAP moiety. This hypothesis is further
supported by detailed DFT calculations, which take into account solvent eﬀects on excited state
dynamics. Cell-free steady-state and time-resolved optical studies on the interaction of the new
complex with duplex and quadruplex DNA show that the complex binds with high aﬃnity to both
structures and indicate that its photoexcited state is also quenched by DNA, a process that is
accompanied by the generation of the guanine radical cation sites as photo-oxidization products. Like
the parent complex, this new compound is taken up by live cells where it primarily localizes within the
nucleus and displays low cytotoxicity in the absence of light. However, in complete contrast to
[{RuII(phen)2}2(tpphz)]
4+, the new complex is therapeutically activated by light to become highly
phototoxic toward malignant human melanoma cell lines showing that it is a promising lead for the
treatment of this recalcitrant cancer.
Introduction
A promising and emerging therapeutic regime for the treatment
of cancer is photo-dynamic therapy (PDT).1,2 In this approach
a photo-excitable sensitizer molecule is used to generate highly
reactive species, most commonly singlet oxygen, 1O2, in situ.
Whilst a number of PDT sensitizers have reached clinical trials,
there are still very few successful commercial examples avail-
able; those that are currently employed frequently display poor
water solubility and do not target cancer cells with high speci-
city, leading to generalized photosensitivity and oﬀ-target toxic
side eﬀects.3 Moreover, these agents are oen challenging to
synthesize and so can be costly. Furthermore, whilst the
generation of 1O2 is essentially a photocatalytic process, one of
the drawbacks of this approach is that many tumours are
hypoxic, which can restrict the eﬃcacy of PDT in these
circumstances.
One alternative to conventional PDT involves the use of
water-soluble polypyridyl d6–metal complexes as sensitizers as,
on photo-excitation with visible light, these complexes oen
possess long-lived triplet states. Because their synthesis from
specic metal ions and ligands is essentially modular, the
photophysical and biophysical properties of these complexes
are easily tuned.4–8 and RuII complexes have attracted particular
attention as sensitizers.9–18
For similar reasons, this class of compounds has also been
investigated as probes for optical microscopy. A case in point is
the probe described in previous reports by the Thomas group.
We have identied a dinuclear RuII complex, [{(phen)2Ru}2(-
tpphz)]4+, 14+,19,20 (phen ¼ 1,10-phenanthroline, tpphz ¼ tetra-
pyridophenazine), Scheme 1, whose biophysical properties are
related to the ubiquitous [Ru(bpy)2(dppz)]
2+
“light-switch”
complex (bpy ¼ 2,20-bipyridyl, dppz ¼ dipyridophenazine).21,22
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Like the parent compound, 14+ is virtually non-emissive in
aqueous solution but – on high-aﬃnity binding to DNA – it
displays the familiar bright, 3MLCT-based, luminescence.
Strikingly, the emission of 14+ is dependent on DNA structure:
whereas binding to canonical duplex DNA induces NIR emis-
sion centred at 680 nm, binding to G-rich, quadruplex folded,
human telomere sequence – (30-TTAGGG-50)n – leads to emis-
sion at 650 nm and a greater enhancement of emission (150
vs. x60).19,23 Detailed subsequent studies, including co-
localization with nucleic acid stains and TEM imaging,
conrmed that 14+ is taken up by live cells, where it localizes
within the nucleus imaging heterochromatin duplex and
quadruplex structures.24
This observation is particularly signicant, as quadruplex
structures have been hypothesized to have roles in a range of
biological processes, including modulation of gene expression,
epigenetics, nucleating of DNA replication, and genetic
disease.25–30 Consequently, this has led to a plethora of research
into these non-canonical structures, including work on telo-
meres. Single stranded telomere sequences are found at the end
of chromosomes and, as outlined above, are known to form
quadruplexes. Telomeres are associated with dening the
Hayick limits for cell division: each cell division results in
shortening of the telomere sequence, until a critical length is
reached and senescence is triggered. Given these facts, it is
perhaps not surprising that telomere length maintenance,
leading to cell immortalization, is an almost ubiquitous
phenomenon in cancer cells.31,32 For this reason, selective
methods to facilitate the attrition of telomere length in cancer
cells, which oen involve stabilization of quadruplex structures,
have been sought.32
As 14+ binds to both quadruplex and duplex structures within
live cells, a phototoxic analogue would function as a sensitizer
for PDT that could additionally enhance telomere attrition
rates. To carry out this transformation we changed the ancillary
ligands attached to the central RuII(tpphz)RuII moiety.
Extensive studies have demonstrated that the substitution of
conventional bpy or phen ancillary ligands with the electron
decient ligand tetraazaphenanthrene, TAP, produces
a complex with strikingly diﬀerent photo-excited state proper-
ties.33–37 For example, unlike the parent light-switch complex,
[Ru(TAP)2(dppz)]
2+ is luminescent in water but is quenched by
binding to DNA. This is due to photo-excitation into a RuII/
TAP 3MLCT excited state which photo-oxidizes guanine sites
when intercalated into duplex DNA. In cell free studies, a related
dinuclear complex was shown to be a more eﬃcient at photo-
damaging oligonucleotides containing G than [Ru(TAP)2(-
dppz)]2+ and was particularly eﬀective at creating photo-adducts
when bound to quadruplex folded DNA.38 However, cell studies
on such systems are much less developed. Whilst it is known
that, even aer 24 hours exposure, [Ru(TAP)2(dppz)]
2+ solely
localizes in the cytoplasm of HeLa cells,39 the Keyes group has
demonstrated that covalent attachment of a suitable signal
peptide to a [Ru(TAP)2(bpy)]
2+ unit leads to a construct capable
of targeting cell nuclei. Although this hybrid system possesses
considerable phototoxicity, it is produced on a small scale,
using only 10 mg of metal complex starting material.40 Recently,
the Elias group have reported preliminary studies on mono-
nuclear complexes containing the RuII(TAP)2 moiety coordi-
nated to a quadruplex targeting ligand. Whilst this complex is
phototoxic, so is its RuII(phen)2 analogue, suggesting that the
observed phototoxicity of both complexes may be due to classic
singlet oxygen sensitization.41
This report concerns an essentially iso-structural derivative
of 14+ containing RuII(TAP)2 fragments. In this study we
describe the synthesis, characterization, and crystal structure of
this new complex [{Ru(TAP2)}2(tpphz)]
4+, 24+, which can be
isolated in good yields.
Experimental and computational studies reveal that 24+
displays a Ru/ TAP MLCT excited state and cell free studies
conrm that the complex binds to both duplex and quadruplex
DNA. Photophysical studies conrm that the complex is capable
of photo-oxidizing guanosine monophosphate, GMP and
guanine sites in both duplex and quadruplex DNA. We also nd
the complex is spontaneously taken up by live melanoma cells,
where it localizes in the nucleus and displays potent photo-
toxicity, indicating that it is a readily accessible, highly prom-
ising, photosensitizer for the treatment of a highly malignant
recalcitrant cancer.
Results and discussion
We initially set out to synthesize the TAP ligand following
established literature procedures.34,42 The diaminoquinoxaline
precursor was readily obtained using the route described by
Elmes et al.42 However, in our hands, existing literature proce-
dures for the nal synthesis of TAP from this intermediate
proved to be unreliable and low yielding. We found that by
using isopropanol as the reaction solvent, along with 1.5
equivalents of glyoxal, the production of intractable side-
products could be eliminated, yielding 80% of pure TAP aer
work-up.
Complex 24+ was synthesized through an analogous route to
that used for 14+ (see ESI† for a reaction scheme and experi-
mental details).19 However, in coupling the two {Ru(TAP)2} cores
to the tpphz bridge, we found it was necessary to use more
forcing reaction conditions that for the related phen or bpy
complexes. This is most likely due to the more strongly electron-
decient nature of the TAP ligand reducing the donor strength
of the chelating N lone pairs. A microwave-assisted synthesis
adapted from a previous report,39 combined with purication
Scheme 1 Structures of 14+ and 24+.
Chem. Sci. This journal is © The Royal Society of Chemistry 2019
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through alumina column chromatography and then ion-
exchange chromatography on Sephadex-LH25 yielded analyti-
cally pure 24+ as a chloride salt in 55% yield. For spectroscopic
studies, the hexauorophosphate was also isolated by anion
metathesis.
Crystals suitable for X-ray crystallography were grown by
slow vapour diﬀusion of acetone into a saturated solution of 24+
in methanol. Although the quality of the data (R ¼ 9.27)
prevents a full analysis of bond length and angles, it does
conrm connectivities. Interestingly, like the corresponding
structure of [{(bpy)2Ru}2(tpphz)]
4+,43 the resultant unit cell
contains two stereoisomers of 24+ – the D,D and L,L forms –
with no evidence of the meso D,L form apparent in the crystal
data. One of these cations (the D,D cation) is shown in Fig. 1.
Two of the chloride counter ions are disordered, and
a number of highly disordered water molecules are present
within a solvent cavity, which were accounted for in the
renement using a solvent mask.
The distorted octahedral geometry around each ruth-
enium(II) core is essentially identical, with a N1–Ru1–N6 angle
of 171.8 and the average bond length for the 4 TAP ligands of
2.052 A. The tpphz bridging ligand displays a marked twist – the
angle between the planes of the two “bpy”moieties of the tpphz
gives a twist of 10.4. As might be expected, the observed bond
angles and lengths are comparable to those of
[{(bpy)2Ru}2(tpphz)]
4+.
The UV/Vis absorption spectra of [2](PF6)4 and [2]Cl4 were
measured in acetonitrile and water respectively. Apart from the
expected high-energy intraligand bands, the complex possesses
an absorption between 400–500 nm, an energy that is typical for
a Ru / L 1MLCT transition, see Fig. 2 and Table 1, but it is
substantially more intense than the equivalent transition for
1
4+. The energy of the 1MLCT does not signicantly change in
acetonitrile compared to aqueous environments, although
changes in relative intensities within the band suggests that it is
composed of at least two intense, overlapping transitions.
The emission spectra of [2](PF6)4 and [2]Cl4 were also
measured in acetonitrile and water respectively (Fig. 2, Table 1).
The complex displays bright emission between 600–750 nm in
both solvents, which is in direct contrast to the properties of
1
4+,19 which is quenched in aqueous media.44 The emission
wavelength and lifetimes in acetonitrile were very similar to
those in aqueous conditions, with only a small blue shi in lmax
alongside an approximately 20% decrease in emission lifetime
and quantum yield. These observations reveal a signicant
diﬀerence in the lowest excited state of 24+ compared to 14+,
suggesting that – as expected – the emissive state of 24+ is a TAP-
based 3MLCT rather than the tpphz-based 3MLCT of 14+. As
expected from these observations, emission quantum yield are
similar, regardless of solvent environment.
The electrochemical properties of 24+ were investigated in
dry acetonitrile. The complex displays a single oxidation at
approximately 1.8 V vs. Ag/AgCl, which appears to be reversible,
although it occurs at the edge of the solvent window. This
potential is almost identical to that reported for the mono-
nuclear [Ru(TAP)2dppz]
2+ complex34 (+1.82 V vs. Ag/AgCl), and is
therefore assigned to the expected reversible RuII/III oxidation.
The reduction of the complex in acetonitrile results in a large
stripping peak on the return sweep. This behaviour has been
previously observed for dinuclear complexes with a tpphz
bridge44 and suggests the reduced form of the complex displays
low solubility in MeCN. Therefore, the reduction potentials
were also measured in dry DMF (Fig. 3).
Several reduction waves are observed in these conditions.
Two distinct reversible reductions occur at0.70 V and0.86 V,
with further poorly resolved couples occurring between 1.4 to
1.8 V. Given that the emissive state of [2]Cl4 is not quenched in
water, which implies a TAP-based lowest excited state, the
reduction at0.70 V is assigned to the rst reduction of the TAP
ligand, which is similarly observed in the mononuclear Ru–TAP
analogues.33,45 A second reduction process at 0.86 V is also
consistent with the reduction of a TAP ligand coordinated to the
second Ru centre. Through comparison to related complexes,
the overlapping redox processes between 1.4 V to 1.8 V are
assigned to a combination of reductions of the tpphz bridging
unit, and further reductions of TAP ligands.
To elucidate our results further a series of density functional
calculations using Gaussian 09 (ref. 46) was performed
employing methods and procedures outlined in the ESI.†Fig. 1 Thermal ellipsoid diagram showing the D,D cation of the [2]Cl4
structure. Hydrogen atoms have been omitted for clarity.
Fig. 2 UV/Vis absorption spectra (left) and emission spectra (right) of
[2]Cl4 and [2](PF6)4 in water, acetonitrile and phosphate buﬀer (10 mM
KH2PO4, 200 mM KCl, pH 7.2, 20 mM EDTA).
This journal is © The Royal Society of Chemistry 2019 Chem. Sci.
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Calculations were performed on 14+ in acetonitrile and on 24+ in
both acetonitrile and water. In these calculations, we included
solvent using a continuum model for MeCN. However, from
previous work,47 it is clear that some explicit water molecules
are needed to describe the electronic structure of these
compounds in water correctly, especially since it is known that
hydrogen bonding plays an important role in the excited states
dynamics of complexes such as 24+.
The nal optimized structures for the triplet states are given
in Fig. 4, with the spin density super-imposed on the nal
structure. In these calculations, the singlet (ground-state)
structures are indistinguishable from the triplet structures
and can be found in the ESI.†
The spin densities and geometries in Fig. 4 show very clearly
that, although replacing phen with TAP has little structural
eﬀect, the substitution leads to signicant electronic changes.
In particular, the spin density clearly shows that for 24+ (irre-
spective of the solvent) the triplet excited state has its density on
one of the TAP ligands, whereas for 14+ it is situated on the
tpphz, conrming our experimental observations (vide supra).
Close inspection of the LUMO and LUMO+1 orbitals shows that
these are part of a (near-) degenerate pair, so that small
geometric distortions may alter the specic TAP on which the
excited state localizes.
In the calculations associated with Fig. 4c, water molecules
were placed in hydrogen-bonding positions around 24+. These
interactions will be associated with many orientations of very
similar energies. However, an exhaustive search on this issue is
outside the scope of this paper and will most likely lead to very
Table 1 Photophysical data for complex 24+
Complex
Absorption Emission
lmax (nm) 3 (L mol
1 cm1) lmax (nm) Quantum yield Lifetime (ns)
[2]Cl4
a 423 41 800 628 0.05 (water) 650  24
452 33 300 0.04 (phosphate) 575  37
0.07 (Tris) 723  23
[2](PF6)4
b 423 41 800 613 0.04 550  30
452 34 800
a Measured in H2O.
b Measured in MeCN.
Fig. 3 Cyclic voltammogram for 1 mM [2](PF6)4: in dry DMF with 0.1 M
N(n-Bu)4PF6 supporting electrolyte. Red and blue lines show isolated
sets of reductions.
Fig. 4 Lowest triplet structures for 14+ in MeCN [panel (a)], 24+ in
MeCN [panel (b)], and 24+ in water [panel (c)]. Blue indicates a spin,
whereas red indicates b spin.
Chem. Sci. This journal is © The Royal Society of Chemistry 2019
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similar results. Nevertheless, it is interesting to note that two
water molecules bonding to the central tpphz moiety, which
were originally placed in a hydrogen-bonding position, rotated
and are in a hydrogen-accepting orientation in the nal struc-
ture. This observation suggests that the nitrogen atoms of the
tpphz bridge are not accessible to hydrogen-bonding, indicating
that some of the deactivation pathways available to similar
complexes incorporating the RuII(dppz) unit cannot be accessed
by 24+.
Using the singlet geometries, UV-VIS spectra were simulated
through TD-DFT calculations, which show qualitative agree-
ment with the experimental absorption spectrum (see ESI Fig. S-
9†). However, our calculations also show that there are many
transitions underlying absorption bands in the visible region.
To investigate whether the nature of the transitions is aﬀected
by changing the solvent from MeCN to water, a wave function
analysis48–50 was performed on the highest y states in the TD-
DFT calculation. The strongest ve transitions from this anal-
ysis are also represented graphically in the ESI (see Fig. S-10).†
The wave function analysis indicated that transitions in both
solvents occur at similar energies, resulting in what appear to be
the near-identical experimental UV-VIS spectra shown in Fig. 2.
However, it is also clear that the nature of each of these tran-
sitions is very diﬀerent.
Again, the analysis yields results that are consistent with the
experimental data. For example, in MeCN and water, transitions
with similar energy – at 425.8 and 421.0 nm, respectively – are
predicted. Yet, whilst this transition in MeCN is assigned to
a MLCT from both Ru atoms onto the tpphz bridge, in water the
transition is predicted to be aMLCT from the Ru atoms onto the
TAP units. Interestingly, some of the transitions are completely
diﬀerent in their nature. For example, transitions at 389.1 nm
and 386.5 nm in MeCN are again MLCT transitions onto tpphz,
but in water, where these transitions occur at 385.0 nm and
381.0 nm, respectively, they are inter-ligand transitions from
tpphz onto TAP for the latter transition and amix of inter-ligand
transitions and an MLCT transition for the former transition.
The calculated triplet geometries and corresponding singlet
states were also used to predict the emission wavelength
assuming no geometrical relaxation. In MeCN, the emission
maximum of 24+ was calculated to be at 647 nm and in water the
corresponding wavelength was predicted to be 677 nm. The
corresponding emission wavelengths for the 0–0 transitions
(which includes geometric relaxation) were at 607 and 637 nm,
respectively. In both cases, there is a correlation with both the
ordering and approximate energies of experimentally measured
spectra as shown in Fig. 2.
Finally, the behaviour upon reduction of these complexes
was investigated computationally. The diﬀerences in electron
density for the rst and second reduction of 24+ in both MeCN
and water were calculated and are shown in Fig. 5.
Concentrating on the panels (c) and (d) rst, the calculations
are in agreement with the experimental data. They clearly
indicate that both reductions are mainly centred on the TAP
ligands. It is also clear that the water molecules do not play
a direct role in the reduction, in that there is no density
diﬀerence associated with them. However, water molecules do
respond to the reduction by adapting their orientation with
respect to 24+ as is clear from panel (d), where the water mole-
cules bonded to the tpphz ligand in 23+ are polarized towards
the reduced TAP ligand.
The situation in MeCN as shown in panels (a) and (b) of
Fig. 5 is somewhat diﬀerent. Here, the rst reduction is of the
tpphz ligand, whereas the TAP ligands are reduced in the
Fig. 5 Diﬀerence density maps for 22+ in acetonitrile [panels (a) and
(b)] and water [panels (c) and (d)]. Panel (a): Diﬀerential density for
reduction from 24+ to 23+ in MeCN. Panel (b): Diﬀerential density for
reduction from 23+ to 22+ in MeCN. Panel (c): Diﬀerential density for
reduction from 24+ to 23+ in water. Panel (d): Diﬀerential density for
reduction from 23+ to 22+ in water. Blue indicates increase of electron
density, whereas red indicates loss of electron density (see ESI for the
methodology used).
This journal is © The Royal Society of Chemistry 2019 Chem. Sci.
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Fe
br
ua
ry
 2
01
9.
 D
ow
nl
oa
de
d 
on
 3
/1
5/
20
19
 3
:4
3:
13
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
second reduction. This is in line with the virtual orbitals of 24+
in MeCN, but is diﬀerent from what happens upon photo-
excitation, where the triplet state is clearly located on the TAP
ligand. Clearly, these virtual orbitals are close enough to facil-
itate this re-arrangement upon reorganization of electron
density. It should be pointed out that this result is slightly
diﬀerent to the observed electrochemistry for [2](PF6)4; however,
the experimental data were collected in DMF and it the calcu-
lations indicate that the electronic structure of this system is
solvent dependent.
Given the interesting redox properties of 24+ revealed by the
experimental data and computational studies, the photo-
oxidizing properties of the complex were investigated.
It has previously been demonstrated that [Ru(TAP)2(dppz)]
2+
and related complexes photo-oxidize DNA through electron
transfer from guanine sites to the photo-excited complex,
quenching its emissive state.33–36,51 Therefore the eﬀect of
increasing concentrations of nucleotide monophosphates on
the emission spectrum of 24+ was investigated and as expected
these revealed that only addition of GMP led to emission
quenching (Fig. 6).
The diﬀerence between I0/I and s0/s as a function of
quencher concentration indicate that emission changes are
caused by both dynamic and static quenching processes. Such
eﬀects oen occur through stacking interactions between
nucleotides and luminophores,52,53 therefore this possibility was
investigated using 1H-NMR.
Although distinct changes in the chemical shis for
a number of protons on 24+ were observed on addition of GMP,
these were diﬃcult to quantify as they were accompanied by
signicant signal broadening. However, signicant chemical
shis were simultaneously observed for several GMP signals.
Notably, the purine proton at the 8-position shied from d 7.95
to 8.06, and the 10 sugar proton d 5.60 to 5.75. Fitting these latter
changes to a simple 1 : 1 guest–host binding model gave a Ka of
8.3  102 M1. It is known that large anions can interact with
dinuclear complexes by binding into the cle dened by
ancillary and bridging ligands. Indeed, this has formed the
basis of chromatographic separation of stereoisomers of such
complexes.54–56 Thus, the observed NMR shis indicate that
GMP interacts with 24+ in this manner.
The emission quenching data were then tted using the
relationship:57
I0
I
¼

1þ kqs0½Q

ð1þ Ka½QÞ:
Where, kq is the quenching constant, s0 is the emission lifetime
of 24+ without a quencher, [Q] is quencher concentration and Ka
the association constant. This analysis gives a quenching
constant of 1.2  108 M1 s1. No signicant emission
quenching was observed on addition of A, T and C mono-
phosphates conrming that – as expected from previous studies
– quenching was exclusive to GMP.
For the interaction of 24+ with both duplex and quadruplex
DNA was the investigated through absorption and lumines-
cence titrations. To aid comparisons, all titrations in these
studies (and the ESI†) were carried out in high ionic strength
phosphate buﬀer, which is consistent with quadruplex folding
(10 mM KH2PO4, 200 mM KCl, 0.1 M EDTA, pH 7.0). Absorption
measurements were taken in parallel, both to assess any
changes in the absorption spectrum itself and to correct the
emission intensities.
As expected from the GMP experiments and similar studies
on [Ru(TAP)2(dppz)]
2+, complex 24+ shows emission quenching
on binding to CT-DNA – Fig. 7A.34,36 Again, this observation is
consistent with a RuII / TAP-based 3MLCT excited state and
indicates the expected photoredox quenching by G-sites within
the duplex. This is conrmed by the fact that addition of
poly(A)–poly(T) causes a slight increase in emission (see ESI†).
DNA-induced changes were also observed in the absorption
spectrum of 24+ – Fig. 7B. The MLCT transition at 420 nm shows
a signicant decrease in intensity throughout the titration.
Approaching the end point of the titration, a new shoulder at
460 nm appears to grow in, suggesting that binding to CT-DNA
may aﬀect the energy of excited states. This is consistent with
the previously described DFT calculations indicating that order
of the close lying excited states of the complex is sensitive to its
environment.
Attempts to t the titration data to the well-known McGhee–
von Hippel model58 were unsuccessful; it is possible that this is
due to the presence of multiple binding modes. However, the
absorbance data tted well to the simpler binding model
described by Srishailam et al.,7 Fig. 7C, resulting in an estimated
Kb of 2  10
6 M1, which is of the same order of magnitude as
isostructural 14+,19 implying the addition of the heteroaromatic
nitrogens to the ligands does not signicantly aﬀect binding to
duplex DNA.
Previous work within the Thomas group has shown that 14+
binds to quadruplex-folded human telomere sequence (HTS)
with high aﬃnity.19,20,23 Therefore, analogous experiments were
Fig. 6 Stern–Volmer plot for the emission of [2]Cl4 quenched by the
addition of guanosine monophosphate, showing change in lifetime
and emission intensity.
Chem. Sci. This journal is © The Royal Society of Chemistry 2019
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carried out with 24+ using the same experimental conditions.
HTS-induced changes in emission spectra are similar to those
observed on CT-DNA addition; as HTS is G-rich quenching by G-
sites is again expected – Fig. 7D. However, a closer inspection
reveals diﬀerences in the absorption changes induced by
binding to HTS and CT-DNA – Fig. 7E. In particular, whilst an
initial decrease in absorption of the 423 nm band is observed on
addition of HTS, the subsequent grow-in of the band at 460 nm
observed in duplex binding does not occur, suggesting that
binding to quadruplex does not aﬀect the energy of excited
states of 24+ in the same way as duplex binding.
The emission titration data was also best tted to a one-set-
of-sites binding + non-specic interaction model – Fig. 7F.
This yielded an estimated binding constant of 5.1  105 M1,
which is an order of magnitude lower than the binding
constant to the duplex and twenty-fold lower than the binding
of 14+ to HTS.
The diﬀerence in quadruplex binding aﬃnities between the
two complexes may be explained by a consideration of our
previously reported NMR-based HTS/14+ structure, which shows
close contacts between the ancillary ligands of 14+ and the
diagonal loops of the quadruplex structure. It seems the lone
pairs of the aromatic nitrogen of the ancillary TAP ligands
destabilizes this interaction through unfavourable interactions
with similar basic sites within the diagonal loop.
To further investigate the changes in the excited state of DNA
bound 24+ transient absorption experiments were carried out.
Absorption transients were measured in phosphate buﬀer at
a concentration of 0.1 mM complex – Fig. 8 and 9. Global life-
time analysis of the TA data was carried out using Glotaran
1.5.1,59 with kinetics of selected processes tted using Origin
8.0.
Previous studies on Ru complexes of dppz and tpphz have
revealed that intense transient bands in the 500–800 nm region
are produced by charge transfer to the phenazine moiety of the
ligands.36,60–63 However, the computational and steady-state
optical studies described above suggested that the lowest
excited state for complex 24+ is a Ru / TAP MLCT. These
conclusions are further supported by the transient spectra for
[2]Cl4 which show that the strong ground-state bleach of the
MLCT absorption bands between 400–500 nm is accompanied
by the growth of a weak transient between 500–650 nm, changes
which occur immediately following the pump pulse (within 1
ps) – Fig. 8A. These observations are consistent with previous
studies on [Ru(TAP)2(dppz)]
2+ in solution – which also shows
a weak, broad, largely featureless transient absorption between
500–650 nm – and conrm that 24+ displays a TAP centred
excited state.34,64
There are no signicant changes in spectral shape
throughout the time-window of the experiment (7900 ps).
Fig. 7 CT-DNA and HTS titration data for [2]Cl4 (5 mM concentration, in phosphate buﬀer). (A) Changes in emission spectra upon addition of CT-
DNA. (B) Changes in absorption spectra with CT-DNA. (C) Binding curve for the data obtained with CT-DNA based on absorption data – red line
shows ﬁt to model developed by Srishailam et al.7 (D) Changes in emission spectra upon addition of HTS. (E) Changes in absorption spectra of [2]
Cl4 upon addition of HTS. (F) Binding curve for [2]Cl4 with HTS based on emission data – red curve shows ﬁtting to a one-set-of-sites binding +
non-speciﬁc interaction mode.
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Global tting of the spectra using 4-exponential decay param-
eters gave the most reliable tting of the data. The two fastest
components of under 1 ps, are followed by simultaneous
decay of the entire spectrum, with components of 355 ps and
100 ns. The slow component is assigned to the emissive
excited state observed above. The 355 ps component is likely to
be due to conversion of a multitude of initially-formed excited
states to the long-lived Ru/ TAP 3MLCT state, as lifetimes of
a similar order of magnitude have been previously observed for
[Ru(TAP)2(dppz)]
2+ and related complexes.
Signicantly, in both the CT-DNA and HTS experiments, but
not a distinctive signal at approximately 515 nm emerges –
Fig. 9. A very similar transient is observed when DNA is added to
[Ru(TAP)2(dppz)]
2+ and this was assigned to the generation of
the guanine radical cation as a photo-oxidization
product.35,36,64,65 Interestingly, this feature is appreciably more
prominent on addition of HTS, which as a sequence possesses
a higher density of G-residues compared to CT-DNA, and is
therefore more likely to undergo photo-oxidation on exposure to
light.
The excited state dynamics of 24+ in the presence of CT-DNA
and HTS are complex, with global lifetime analysis suggesting
a minimum of four distinct excited state processes. The life-
times of these states are of similar magnitude in the presence of
both CT-DNA and HTS (Table 2).
The decay-associated spectra (see ESI‡) for each excited state
process feature a grow-in signal at510 nm, associated with the
photooxidation of guanine. This implies that this photo-
oxidation process can occur in parallel from multiple excited
states. Unfortunately, there is insuﬃcient detail in the transient
absorption data to accurately model these processes. However,
by isolating and tting the feature at 510 nm using a 3-expo-
nential model, the major lifetime component of this growth is
1808  100 ps for CT-DNA and 1592  90 ps for HTS. The faster
kinetics for HTS is consistent with the anticipated intimate
contact between 24+ and guanine tetrads of the four-stranded
structure.
The intricacies of the dynamics reect the complexity of
binding modes and the numerous potential photochemical
pathways following photoexcitation. Assuming the lowest triplet
excited state of the complex is a Ru / TAP 3MLCT state (as
conrmed by the calculations), then subsequent simultaneous
photooxidation of guanine, radiative and non-radiative decay,
Fig. 8 Selected transient absorption data for [2]Cl4 following 40 fs, 400 nm excitation. (A) In phosphate buﬀer. (B) In phosphate buﬀer with
1 mM CT-DNA. (C) In phosphate buﬀer with 1 mM HTS.
Fig. 9 Selected transient absorption spectra for [2]Cl4 in phosphate
buﬀer with and without CT-DNA and HTS, showing the growth of the
transient band at 515 nm.
Table 2 Lifetimes obtained from global lifetime analysis of transient
absorption data
Lifetimes (ps)
CT-DNA HTS
s1 3.6  0.4 2.9  0.2
s2 275  12 330  17
s3 2900  150 2930  130
s4 >30 000 >30 000
Chem. Sci. This journal is © The Royal Society of Chemistry 2019
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as well as c of the oxidised guanine residues will all contribute
to the spectral evolution. Signicantly more detailed analyses,
such as time-resolved infrared spectroscopy, will be required to
fully dissect the subtleties, which will form the basis of a future
report. Nevertheless – although it is clear that 24+ preferentially
binds to duplex over quadruplex DNA – the cell-free studies
described above conrm that this complex does participate in
photo-induced redox reactions with G-sites, whether they are
found in duplex or quadruplex structures.
With these promising results in mind, the live cell uptake
and localization of 24+ was investigated. For reasons of thera-
peutic need, malignant humanmelanoma cells were specically
chosen for these studies.
Melanoma is one of the most aggressive and therapeutically
resistant cancers. If diagnosed and treated in its early stages it
has an 80% 10 year remission rate. However, if it spreads to the
lymph nodes this gure drops to only 10%.66 In 2017 malignant
melanoma was responsible for 72% of skin cancer deaths in the
USA and its incidence continues to rise.67 One of the diﬃculties
in treating melanoma is that it displays a range of therapeutic
resistance mechanisms,68 so alternative treatment regimes are
being actively sought.69 In this context, it has been suggested
that PDT could provide a novel therapeutic modality for this
cancer.66,70 We chose to investigate the eﬀect of 24+ on human
C8161melanoma cells as this line is known to be highly invasive
and spontaneously metastatic,71 and thus it represents a rele-
vant and therapeutically challenging treatment target.
Encouragingly, it was found that the complex was sponta-
neously taken up by live C8161 cells, and it produced bright
intracellular emission. Furthermore, co-staining using 24+ (100
mM, 24 hours) and the standard nuclear stain DAPI, reveals
DAPI co-localizes with the new complex, displaying a Pearson
coeﬃcient of 0.51. These observations conrm that – like its
close analogue 14+ – complex 24+ is cell and nuclear membrane
permeant. However, unlike 14+, treatment with 24+ also leads to
bright emission from the cytoplasm of the melanoma cells,
therefore analogous co-staining experiments with commercial
stains were carried out, Fig. 10.
These studies revealed some correlation between the emis-
sion of the complex and that of the MitoTracker Green and
LysoTracker Green labels. However, calculated Pearson coeﬃ-
cients of 0.12 and 0.06, respectively, indicate localization of 24+
within these organelles is signicantly lower than within nuclei.
This is consistent with recent super-resolution and TEM
studies72 that revealed that, while 14+ is only brightly emissive
from the nucleus, it does exhibit signicant mitochondrial
localization. The diﬀerence in the intracellular luminescence of
the complexes can be attributed to the fact that whilst 14+
displays oﬀ/on DNA light-switch emission, 24+ is emissive,
unless quenched by photo-redox processes.
To facilitate a more detailed understanding of cellular
uptake, the concentration- and time-dependent uptake of 24+
was explored – see ESI.† It was found that intracellular emission
intensity correlates with increased concentrations and exposure
times. These studies conrmed that the complex readily
diﬀuses into cells, where initially it predominately labels the
nucleus, but then diﬀuses more generally throughout the cell.
Having established uptake by live melanoma cells and
specic sub-cellular localizations, the cytotoxicity and photo-
toxicity of 24+ was then investigated. Cell viabilities aer expo-
sure to diﬀerent concentrations of the complex in the dark aer
24 hours were quantied using the AlamarBlue method –
Fig. 11.58–60
These studies indicated that the initial seeding density of 1
 105 cells per well does not change on treatment with the
complex. Indeed, at all concentrations, no statistical diﬀerence
in cell viability was observed compared to cells of non-treated
controls, suggesting the complex displays negligible cytotox-
icity in dark conditions (see ESI†). Experiments were then
carried out in which melanoma cells treated with various
concentrations of complex were irradiated into the MLCT band
using a 405  20 nm LED laser. Light treated cells were then
incubated for 3 hours, and a change in cell viability measured,
and plotted against various concentrations of 24+.
Irradiation at low uences, with a maximum of only 18 J
cm2, showed a dose–response hyperbolic curve, revealing
a radical drop to eﬀectively zero cell-viability at exposure to 100
mM of 24+, compared to non-irradiated cells. A similar pattern of
concentration-dependent cell death was also seen on exposure
to a broad-spectrum blue light, a regime commonly employed
by dermatologists in the treatment of topical skin conditions
such as acne.73 We note that this treatment required longer time
Fig. 10 Intracellular localization and uptake of [2]Cl4 in human C8161
melanoma cells – labelled Ru–Ru TAP in diagrams. Co-staining with
cytoplasm stains LysoTracker Green (top) and MitoTracker Green
(bottom) show low colocalisation with [2]Cl4 (Pearson coeﬃcient ¼
0.06 0.01, and 0.12 0.04, respectively, SB 10 mm). Co-staining with
nuclear stain DAPI (centre) reveals a signiﬁcantly higher co-localisation
(Pearson coeﬃcient ¼ 0.51  0.19, scale bar ¼ 10 mm).
This journal is © The Royal Society of Chemistry 2019 Chem. Sci.
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exposures, but this is probably due to diﬀerences in power
output. Nonetheless, the new complex is therapeutically active
at uences that are around an order of magnitude lower than
those commonly employed for commercial sensitizers in the
treatment of cancer, including basal cell skin cancer.74–77
Conclusions
Complex 24+ displays similar photophysical properties to
previously reported systems based on the (TAP)2Ru
II moiety in
that it displays a reactive Ru / TAP MLCT excited state that
photo-oxidizes guanosine moieties. Steady-state and time-
resolved studies indicate that the complex participates in
similar process when bound to both duplex and G-rich, quad-
ruplex DNA. Crucially, this new compound is spontaneously
taken up by live melanoma cells, largely localizing in nuclei. The
complex shows no toxicity under dark condition, even at high
concentrations (e.g. 200 mM). However, once sensitized with
light, it becomes highly toxic to humanmelanoma cells, making
it an eﬃcient and promising lead as a photosensitizer for PDT.1
Complex 24+ binds to a quadruplex structure with aﬃnities
that are around an order of a magnitude weaker than those
displayed for duplex binding. Given that conventional duplex
DNA vastly outnumber putative quadruplex sequences within
the genome,78–81 it seems likely that the photo-cytotoxic eﬀects
of this complex is largely due to damage to duplex sequences.
However, damage to quadruplex structures could still be
disproportionately large. Previous studies using photo-redox
active metal complexes have demonstrated that G-rich
sequences, particularly runs of neighbouring G-sites, are
susceptible to redox damage,51,82 even when distal to the metal
complex binding site.83–86 Furthermore, experimental evidence
has accrued that quadruplexes can behave as oxidative traps for
long-range charge-transfer.87,88 For this reason it has been sug-
gested that telomeres may be oxidation hot-spots or traps for
oxidative damage to genomic content.88,89 Inter alia, future
studies involving 24+ will assess the likelihood of this hypoth-
esis. Inspired by this lead, the synthesis of related photo-redox
active structures that display higher selectively for quadruplex
over duplex DNA would provide a novel form of telomere tar-
geted PDT; work on targeting such structures is currently
underway.
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